Metraipolis › archive › dc_6ec117be8332
Real-World Utilisation and Cost Trends of Mineralocorticoid Receptor Antagonists in England: A Population-Level Prescribing Analysis From 2022 to 2025 — Europe PMC PMID:42740667
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42740667
- DOI
- 10.1155/cdr/5473277
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T04:47:56.367Z
- SHA-256 of the archived text
ea8f4564424152ca794e04d336d052906842288e03b120c002b3b2f234ee997a- Stable URL of this page
https://metraipolis.com/documento/dc_6ec117be8332
How to cite
Real-World Utilisation and Cost Trends of Mineralocorticoid Receptor Antagonists in England: A Population-Level Prescribing Analysis From 2022 to 2025 — Europe PMC PMID:42740667 — Europe PMC (en), https://europepmc.org/article/MED/42740667 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ec117be8332 (Metraipolis archive dc_6ec117be8332, sha256 ea8f4564424152ca794e04d336d052906842288e03b120c002b3b2f234ee997a)
BibTeX
@misc{dc6ec117be8332,
title = {Real-World Utilisation and Cost Trends of Mineralocorticoid Receptor Antagonists in England: A Population-Level Prescribing Analysis From 2022 to 2025 — Europe PMC PMID:42740667},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42740667},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ec117be8332; sha256 ea8f4564424152ca794e04d336d052906842288e03b120c002b3b2f234ee997a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42740667. Agents can read the archived copy with the MCP tool read_document.